David A Cano Selected Research

David A Cano Research Topics

9	Neoplasms (Cancer) 01/2022 - 10/2008
9	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 02/2014
5	Acromegaly 04/2019 - 01/2013
1	Craniopharyngioma (Craniopharyngiomas) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Headache (Headaches) 10/2019
1	Hyperthyroidism 10/2019
1	Tachycardia (Tachyarrhythmias) 10/2019
1	Vision Disorders (Hemeralopia) 10/2019
1	Familial Isolated Pituitary Adenoma 04/2019
1	Prolactinoma (Prolactinomas) 04/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Combined Pituitary Hormone Deficiency 01/2019
1	Insulin Resistance 01/2016
1	Inflammation (Inflammations) 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Adenoma (Adenomas) 11/2015
1	Pituitary ACTH Hypersecretion 02/2014
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Hypoglycemia (Reactive Hypoglycemia) 01/2013
1	Pancreatitis 02/2010
1	Adenocarcinoma 02/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2010
1	Carcinogenesis 10/2008
1	Hyperinsulinism (Hyperinsulinemia) 12/2007
1	Hyperglycemia 12/2007
1	Salmonella Infections (Salmonellosis) 01/2002

7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 11/2015
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2009
4	Insulin-Like PeptidesIBA 01/2019 - 01/2013
4	Growth Hormone (Somatotropin)IBA 01/2019 - 01/2013
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 01/2018
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 12/2007
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 02/2014
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2018
2	Insulin (Novolin)FDA Link 01/2020 - 01/2013
2	Hormones (Hormone)IBA 11/2015 - 01/2013
2	beta CateninIBA 02/2010 - 10/2008
1	CateninsIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022
1	ProlactinIBA 01/2022
1	somatostatin receptor type 1IBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	GhrelinIBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2020
1	Chromogranin AIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 02/2014
1	Glucagon (Glukagon)FDA Link 01/2013
1	GTP Phosphohydrolases (GTPases)IBA 02/2010
1	Oxygen (Dioxygen)IBA 02/2009
1	Exonucleases (3' 5' Exonuclease)IBA 01/2002

4	Therapeutics 04/2019 - 01/2014
1	Transplantation 01/2020
1	Radiotherapy 01/2019
1	Adjuvant Radiotherapy 01/2019
1	Operative Surgical Procedures 01/2019
1	Bariatric Surgery 01/2016